CTOR vs JD · $105.2M cap vs P/E 7.6, rev $187.20B
Citius Oncology, Inc. (CTOR) versus JD.com Inc Adr (JD) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
JD.com Inc Adr (JD) is a internet retail company listed on US.
CTOR does not have a complete income-statement cache yet.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
CTOR currently screens at market cap $105.2M. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Not investment advice. Open the CTOR and JD stock pages for the full models.
Not investment advice.